Mitochondrial 12S ribosomal RNA A1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure

Anne-Sofie Skou, Lisbeth Tranebjærg, Tim Jensen, Henrik Hasle

10 Citations (Scopus)

Abstract

A 19-month-old girl with the A1555G mitochondrial mutation in the 12S ribosomal RNA gene and acute myelogenous leukemia developed dilated cardiomyopathy and bilateral sensorineural hearing loss before undergoing allogeneic stem cell transplantation. She had received gentamicin during episodes of febrile neutropenia. Testing for the A1555G mutation is recommended in patients frequently treated with aminoglycosides.

Original languageEnglish
JournalThe Journal of Pediatrics
Volume164
Issue number2
Pages (from-to)413-5
Number of pages3
ISSN0022-3476
DOIs
Publication statusPublished - Feb 2014

Keywords

  • Aminoglycosides
  • Cardiomyopathies
  • Female
  • Hearing Loss, Sensorineural
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute
  • Mutation
  • Pedigree
  • RNA, Ribosomal

Fingerprint

Dive into the research topics of 'Mitochondrial 12S ribosomal RNA A1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure'. Together they form a unique fingerprint.

Cite this